Ftse Mib
33.935,87
-0,98%
DAX
17.904,91
-0,93%
S&P 500
5.009,39
-1,23%
NASDAQ Composite
15.446,00
-1,70%
Bitcoin
63.629,76
-1,01%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistente personale
Home Investire Azioni Regno Unito LSE Gsk Plc (GSK) Gsk Plc (GSK) Notizie

Gsk Plc

GSK
1.642,50
6,50 (0,40%)
Ultimo aggiornamento: 17:16:10
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
24/4/202410:14ALNCNewsGSK's Jemperli with chemotherapy accepted for priority..
24/4/202408:00LSEG_RNSGSK PLC US FDA accepts new indication filing for Jemperli
19/4/202416:30LSEG_RNSGSK PLC Director/PDMR Shareholding
17/4/202416:30LSEG_RNSGSK PLC Director/PDMR Shareholding
17/4/202409:46ALNCNewsTOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea..
17/4/202408:05LSEG_RNSGSK PLC GSK announces additional EAGLE-1 results
17/4/202408:00LSEG_RNSGSK PLC Results from long-term data relating to Shingrix
16/4/202415:11LSEG_RNSGSK PLC Amendment - Director/PDMR Shareholding
16/4/202409:59ALNCNewsGSK's latest meningitis vaccine accepted for review by US..
16/4/202408:00LSEG_RNSGSK PLC FDA accepts GSK meningitis vaccine candidate file
15/4/202416:30LSEG_RNSGSK PLC Director/PDMR Shareholding
08/4/202411:27ALNCNewsIN THE KNOW: Barclays ups GSK price target but HIV drug..
04/4/202413:05LSEG_RNSGSK PLC Replacement - Total Voting Rights
02/4/202416:00LSEG_RNSGSK PLC Total Voting Rights
26/3/202416:30LSEG_RNSGSK PLC Director/PDMR Shareholding
25/3/202414:00LSEG_RNSGSK PLC Notice of AGM
22/3/202417:20LSEG_RNSGSK PLC Transfer of Treasury Shares
22/3/202416:36LSEG_RNSGSK PLC Director/PDMR Shareholding
18/3/202410:30LSEG_RNSGSK PLC New Phase III Jemperli data in endometrial cancer
18/3/202409:47ALNCNewsGSK says Jemperli combination gets good results for..
13/3/202416:48LSEG_RNSGSK PLC Director/PDMR Shareholding
08/3/202418:12LSEG_RNSGSK PLC Board Committee Change
07/3/202410:38ALNCNewsGSK observes positive data in Blenrep trial for blood cancer..
07/3/202408:00LSEG_RNSGSK PLC GSK announces positive Blenrep DREAMM-8 results
06/3/202417:00LSEG_RNSGSK PLC ViiV LAI vs oral SOC data in adherence-challenged
05/3/202418:24LSEG_RNSGSK PLC GSK Annual Report 2023 on Form 20-F
05/3/202412:03ALNCNewsGSK says ViiV's cabotegravir study supports longer HIV dose..
05/3/202408:00LSEG_RNSGSK PLC New ViiV LA formulation potential 4-month dosing
01/3/202416:00LSEG_RNSGSK PLC Total Voting Rights
01/3/202413:15LSEG_RNSGSK PLC GSK publishes Annual Report 2023
29/2/202410:44ALNCNewsTOP NEWS: GSK avoids "protracted litigation" with Zantac..
29/2/202408:05LSEG_RNSGSK PLC Directorate Change
29/2/202408:00LSEG_RNSGSK PLC Statement: Zantac (ranitidine) litigation
26/2/202416:30LSEG_RNSGSK PLC Director/PDMR Shareholding
26/2/202409:25ALNCNewsGSK gonorrhoea treatment achieves efficacy endpoint in..
26/2/202408:00LSEG_RNSGSK PLC GSK announces positive EAGLE-1 headline results
22/2/202416:30LSEG_RNSGSK PLC Director/PDMR Shareholding
21/2/202410:47ALNCNewsGSK reports encouraging results for ViiV's Cabenuva HIV..
21/2/202408:00LSEG_RNSGSK PLC ViiV LAI superior to orals in adherence-challenged
20/2/202410:01LSEG_RNSGSK PLC Julie Brown - External Appointment
19/2/202416:30LSEG_RNSGSK PLC Director/PDMR Shareholding
15/2/202416:32LSEG_RNSGSK PLC Director/PDMR Shareholding
15/2/202409:49ALNCNewsGSK completes USD1.4 billion purchase of respiratory firm..
15/2/202408:00LSEG_RNSGSK PLC GSK completes acquisition of Aiolos Bio
13/2/202417:45LSEG_RNSGSK PLC Director/PDMR Shareholding - Replacement
13/2/202416:40LSEG_RNSGSK PLC Director/PDMR Shareholding
13/2/202416:35LSEG_RNSGSK PLC Director/PDMR Shareholding
13/2/202416:30LSEG_RNSGSK PLC Director/PDMR Shareholding
13/2/202409:25ALNCNewsIN THE KNOW: Citi turns positive on GSK after seven years on..
12/2/202416:39LSEG_RNSGSK PLC Director/PDMR Shareholding
Apertura: 1.642,00 Min: 1.635,00 Max: 1.656,00
Chiusura: 1.636,00

La tua Cronologia

LSE
GSK
Gsk
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network